**Specifications Table**TableSubject area*Biology*More specific subject area*Type 2 Diabetes, parametric regression analysis*Type of data*Figure, Table*How data were acquired*Blood glucose measurements (Advantage II, Roche Diagnostics), fluid intake measurement in rutin-treated and control human amylin transgenic mice*Data format*Analyzed*Experimental factors*Treatment of human amylin transgenic mice with either rutin (0.5 mg/ml in the drinking water) or water from 21 days of age (weaning)*Experimental features*Weekly blood glucose and fluid intake measurements*Data source location*University of Auckland, Auckland, New Zealand*Data accessibility*Data are presented in this article*

**Value of the data**•These data will be of value to the scientific community working in the area of type-2 diabetes and anti-diabetic therapies since they illustrate the inhibitory effect of a small orally-active molecule on two specific biological parameters reflecting the progression of diabetes in a model that closely mirrors the human disease.•These data will also be of value to biostatisticians working in the area of pre-clinical treatment investigations, as they present a new Bayesian statistical approach for analysing the effect of drug treatment on a key diagnostic criterion employed for diagnosis of diabetes in patients and diabetic animals.•This new Bayesian approach could find application in the evaluation of future therapies for diabetes or other diseases, which have biological parameters that are analysed for clinically relevant impacts.

1. Data {#s0005}
=======

Here we present data illustrating the effects of the dietary flavonol rutin on the blood-glucose (see [Fig. 1](#f0005){ref-type="fig"}A) and fluid-intake profiles ([Fig. 1](#f0005){ref-type="fig"}B) of h-amylin transgenic male mice and their non-transgenic littermates versus mice treated with water (vehicle) only.

We employ a novel parametric change-point regression analysis to extract, for each animal, baseline levels of blood glucose and fluid intake, the change-point time at which blood glucose (diabetes-onset) and fluid intake (onset of polydipsia) accelerated away from baseline, and the rate of this acceleration ([Table 1](#t0005){ref-type="table"}). This enabled more exact measurement of the impact of rutin on the survival of diabetic mice.

2. Experimental design and methods {#s0010}
==================================

2.1. Human-amylin transgenic mice {#s0015}
---------------------------------

Protocols were approved by the University of Auckland Animal Ethics Committee and performed in accordance with the New Zealand Animal Welfare Act (1999), the U.K. Animals (Scientific Procedures) Act 1986, and associated guidelines. All protocols complied with the ARRIVE guidelines [@bib2]. The experimental design for rutin versus water treatment of hA transgenic mice and collection of blood glucose and fluid intake data are described in [@bib1].

2.2. Modelling of time-dependent glucose and fluid-intake data in rutin- and control-treatment groups {#s0020}
-----------------------------------------------------------------------------------------------------

For modelling of time-dependent glucose and fluid intake data in rutin- and control-treatment groups ([Fig. 1](#f0005){ref-type="fig"}A,B), we constructed a non-linear parametric change-point regression model, where each of the three inferred parameters had a clear biological interpretation: (i) A constant baseline component; (ii) A change-point in time where blood glucose or fluid intake begins to deviate from this baseline; (iii) A log-transformed constant acceleration from baseline, beginning at the inferred change-point. The maximum likelihood solution to parametric change-point regression in general is a highly non-convex optimisation problem [@bib3], necessitating grid search or similar. To this end, we performed a Bayesian simulation to sample the posterior distribution of the three parameters for each animal, plus a single normally-distributed residual variance parameter across all animals. All parameters were assigned uninformative uniform prior distributions (truncated to between weaning and death for the change-point parameters, and restricted to non-negative values for the variance parameter). The Stan Hamiltonian Monte Carlo software [@bib4] was employed, which efficiently sampled the posterior distribution despite strong correlation between the change-point and acceleration parameters of each animal. Four chains of 2^18^ iterations (of which 2^17^ were warm-up iterations and with thinning factor 2^5^) were generated from over-dispersed starting values. On the result, the Gelman--Rubin convergence diagnostic [@bib5] strongly suggested the posterior was sampled evenly and not affected by local minima (Rhat\<1.01 and effective sample size \>400 for all parameters). From the generated samples, [Fig. 1](#f0005){ref-type="fig"}A, B show the 95% intervals of Highest Posterior Density (HPD) for the predicted time-courses, and the full posterior distributions for the change-point parameters. These indicate predominantly unimodal fit, together with reasonable estimation uncertainty. Finally, from the marginal posterior of each parameter, the median was extracted and used to seed a maximum likelihood fit to the joint posterior mode, as illustrated. The parameter values for this joint posterior mode are presented in [Table 1](#t0005){ref-type="table"}, and were subsequently used for downstream statistical testing.

Glucose measurements were right-censored (at \>30.0 mM), which was modelled appropriately by the parametric change-point regression analysis model likelihood.

Modelling of the fluid-intake time-course is shown in [Fig. 1](#f0005){ref-type="fig"}B. The fluid-intake time-course had a more complex structure. Firstly, there is typically a transient increase in fluid-intake during adolescence and secondly, fluid-intake in late-stage polydipsia was highly variable between animals. Since the first phenomenon is not directly of interest, we mitigated most of its influence by removing from the analysis all data-points corresponding to times less than the lower HPD boundary of the respective animal׳s inferred blood-glucose change-point. As no inference can be made from the second phenomenon within the current sample size, we removed its effect by right censoring measurements above 30.0 ml/day.

The modelling and inference then proceeded identically ([Fig. 1](#f0005){ref-type="fig"}B) to that for the blood-glucose model ([Fig. 1](#f0005){ref-type="fig"}A). Inflexion points in longitudinal data were determined by parametric change-point regression analysis, which enabled objective fitting of time-response curves ([Fig. 1](#f0005){ref-type="fig"}A, B; [Table 1](#t0005){ref-type="table"}).

Funding {#s0025}
=======

This research was supported by grants from Endocore Research Trust (60147); Maurice and Phyllis Paykel Trust, New Zealand (various equipment grants; 3601069; co-funding of CD-Spectrometer); Health Research Council of New Zealand, New Zealand (HRC 03/190); Ministry of Business, Innovation & Employment, New Zealand (MBIE; UOAX0815); Maurice Wilkins Centre for Molecular Biodiscovery (Tertiary Education Commission 9431--48507); Lottery Health New Zealand (3354520; co-funding of CD-Spectrometer); Medical Research Council, United Kingdom (UK, MR/L010445/1 and MR/L011093/1); Guangdong High-end Foreign Expert Fund; a Key International Collaborative Fund from Chinese Academy of Sciences (154144KYSB20150019,DW); University of Manchester, the Central Manchester NHS Foundation Trust, and the Northwest Regional Development Agency through a combined programme grant to CADET; and was facilitated by the Manchester Biomedical Research Centre and the Greater Manchester Comprehensive Local Research Network.

Transparency document. Supplementary material {#s1035}
=============================================

Supplementary material.

We thank Cynthia Tse for her management and administrative support, and for reading the manuscript, and Professor Sir P John Scott for his helpful discussions with us.

Transparency data associated with this article can be found in the online version at [10.1016/j.dib.2016.11.077](http://dx.doi.org/10.1016/j.dib.2016.11.077){#ir0001}.

![**A.** Blood-glucose profiles of non-transgenic animals (*points*) and transgenic littermates (*crosses*) for the investigation of rutin treatment in hA-transgenic mice (*n*=12 control pairs, *n*=10 rutin-treated pairs). For each pair, the pair׳s weaning and the transgenic׳s day of death are shown as *black-vertical lines*. Each time-course is centred on the transgenic׳s most likely day of diabetes-onset (*red-vertical line*), which was inferred by parametric change-point regression analysis as the time point at which the profile changes from a constant baseline to a constant acceleration from baseline. The most likely fitted profile (joint posterior mode) is shown for each transgenic (*red curve*) and non-transgenic (*dashed-red line*). The uncertainty of the fit is illustrated for each transgenic׳s profile (*grey*, 95% credible interval) and diabetes-onset change-point (*red posterior distribution positioned over the x-axis at day zero*). Results for the conventional method for determining diabetes onset (two consecutive weekly measurements \>11 mM) are also shown (*dotted-red vertical lines*), illustrating the inaccuracy and therefore limited utility of this approach for sensitive between-treatment comparisons. [Fig. 1](#f0005){ref-type="fig"}**B.** Fluid-intake profiles of non-transgenic animals (*points*) and transgenic littermates (*crosses*) corresponding to the blood-glucose profiles shown in [Fig. 1](#f0005){ref-type="fig"}A. Data points removed before parametric modelling are greyed out. Each time-course is centred on the transgenic׳s most likely fluid-intake change-point (*blue-vertical line*), with the respective blood-glucose change-point from [Fig. 1](#f0005){ref-type="fig"}A superimposed (*red-vertical line*). The most likely fitted profile (joint-posterior mode) is shown for each transgenic (*blue curve*) and non-transgenic littermate (*dashed-blue line*). The uncertainty of the fit is shown for each transgenic׳s profile (*grey*, 95% credible interval), and the change-points for blood glucose and fluid-intake (*red and blue posterior distributions respectively, both positioned over the x-axis at their respective change-points*). These posterior distributions illustrate that the fluid-intake change-points are estimated with more certainty than the blood-glucose change-points.(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article)](gr1){#f0005}

###### 

Metadata and parameters inferred from parametric change-point modelling of the control and rutin-treated transgenic mice, together with corresponding results for non-parametric survival analysis (two-tailed Wilcoxon test) and parametric testing (two-tailed *t*-test).

Table 1

  Treatment          ID        **Study metadata**   **Parameters inferred from blood glucose model**   **Parameters inferred from fluid intake model**   **Inferred from both models**                                                                                                               
  ------------------ --------- -------------------- -------------------------------------------------- ------------------------------------------------- ------------------------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
  **Control**        1         514                  257                                                257                                               342                             172         −5.4        10.2        7.9         383         131         −3.7        4.0         3.6         40
  2                  363       217                  146                                                193                                               170                             −5.7        9.8         7.6         246         117         −3.8        3.9         3.1         53          
  3                  168       44                   124                                                61                                                107                             −4.7        9.9         7.1         91          77          −3.5        4.5         3.7         30          
  4                  194       97                   97                                                 88                                                106                             −4.1        10.8        7.8         104         90          −3.6        4.6         4.3         17          
  5                  331       253                  78                                                 233                                               98                              −4.6        9.0         7.6         274         57          −0.7        3.8         --          41          
  6                  158       68                   90                                                 63                                                95                              −3.8        10.9        7.9         90          68          −1.0        5.4         4.0         27          
  7                  182       118                  64                                                 97                                                85                              −4.1        8.9         7.5         114         68          −3.0        7.4         4.4         17          
  8                  276       217                  59                                                 198                                               78                              −5.2        9.0         8.0         238         38          −3.8        4.2         3.7         40          
  9                  95        41                   54                                                 19                                                76                              −4.5        9.1         8.0         50          45          −3.2        4.7         5.0         31          
  10                 155       83                   72                                                 85                                                70                              −3.4        10.1        7.4         98          57          −2.7        4.2         4.4         13          
  11                 143       93                   50                                                 76                                                67                              −2.0        9.5         7.9         80          63          −2.6        4.6         3.9         4           
  12                 236       195                  41                                                 177                                               59                              −3.2        8.5         7.9         186         50          −2.6        8.0         3.6         10          
                                                                                                                                                                                                                                                                                                       
  **Rutin**          1         441                  241                                                200                                               215                             226         −6.3        9.5         6.5         295         146         −4.7        4.5         4.5         80
  2                  295       58                   237                                                75                                                220                             −6.6        10.9        8.2         174         121         −3.4        4.9         4.3         99          
  3                  251       37                   214                                                56                                                195                             −6.2        10.5        7.4         129         122         −5.0        4.5         4.1         73          
  4                  213       78                   135                                                33                                                180                             −6.2        9.5         7.7         121         92          −3.0        5.9         5.3         87          
  5                  353       201                  152                                                184                                               169                             −5.8        9.3         7.7         243         110         −3.4        4.6         4.9         58          
  6                  277       153                  124                                                117                                               160                             −5.1        8.9         7.3         154         123         −4.1        4.5         4.6         36          
  7                  302       70                   232                                                142                                               160                             −5.6        11.5        7.4         193         109         −4.2        4.5         5.0         51          
  8                  161       71                   90                                                 49                                                112                             −4.8        8.7         7.5         79          82          −3.7        4.8         4.5         29          
  9                  129       60                   69                                                 41                                                88                              −3.2        8.1         7.5         55          74          −2.4        4.4         3.8         13          
  10                 140       78                   62                                                 62                                                78                              −3.6        9.1         8.1         79          61          −2.8        5.4         4.6         17          
  **test**                     Wilcoxon             Wilcoxon                                           Wilcoxon                                          Wilcoxon                        Wilcoxon    *t*-test    *t*-test    *t*-test    Wilcoxon    Wilcoxon    *t*-test    *t*-test    *t*-test    Wilcoxon
                               **0.582**            **0.222**                                          **0.044**                                         **0.228**                       **0.011**   **0.030**   **0.932**   **0.276**   **0.974**   **0.014**   **0.059**   **0.744**   **0.009**   **0.036**
  **estimate**       **29**    **−24**              **63**                                             **−27**                                           **68**                          **−1.1**    **0.0**     **−0.2**    **−1.4**    **35**      **−0.8**    **−0.1**    **0.6**     **27.0**    
  **95% CI lower**   **−63**   **−137**             **0**                                              **−123**                                          **9**                           **−2.1**    **−0.9**    **−0.6**    **−92.1**   **6**       **−1.6**    **−1.0**    **0.2**     **0.3**     
  **95% CI upper**   **122**   **26**               **135**                                            **33**                                            **109**                         **−0.1**    **0.8**     **0.2**     **73.5**    **60**      **0.0**     **0.8**     **1.0**     **54.3**    

[^1]: Equal contributions.
